title: Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.
authors.forename: A L
authors.initials: AL
authors.lastname: Endean
authors.forename: S M
authors.initials: SM
authors.lastname: Barry
authors.forename: S A
authors.initials: SA
authors.lastname: Young-Min
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis*; D009894:Opportunistic Infections / Q000139:chemically induced*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007371:Interferon-gamma; D000068879:Adalimumab